Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers.
about
Hippocampal lipid differences in Alzheimer's disease: a human brain study using matrix-assisted laser desorption/ionization-imaging mass spectrometryCambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective propertiesCross-talk of membrane lipids and Alzheimer-related proteins.Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease.Alterations in cerebrospinal fluid glycerophospholipids and phospholipase A2 activity in Alzheimer's disease.Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes.Sphingolipids and brain resident macrophages in neuroinflammation: an emerging aspect of nervous system pathology.Recent advances in lipidomics for disease research.New Perspectives on Alzheimer's Disease and Nutrition.Alzheimer's Disease and ncRNAs.FTIR and Raman Spectroscopy Applied to Dementia Diagnosis Through Analysis of Biological Fluids.Metabolomic-guided discovery of Alzheimer's disease biomarkers from body fluid.Omega-3 fatty acids, lipids and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention.Mild TBI Results in a Long-Term Decrease in Circulating Phospholipids in a Mouse Model of Injury.Hybrid High-order Functional Connectivity Networks Using Resting-state Functional MRI for Mild Cognitive Impairment DiagnosisCurrent and Emerging Technologies for Probing Molecular Signatures of Traumatic Brain Injury.High-order resting-state functional connectivity network for MCI classification.Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analysesRole of LDL cholesterol and endolysosomes in amyloidogenesis and Alzheimer's disease.Alzheimer's disease (AD) as a disorder of the plasma membrane.Mechanisms governing the fragmentation of glycerophospholipids containing choline and ethanolamine polar head groups.Phenolic Extracts from Clerodendrum volubile Leaves Inhibit Cholinergic and Monoaminergic Enzymes Relevant to the Management of Some Neurodegenerative Diseases.Embedded in the Membrane: How Lipids Confer Activity and Specificity to Intramembrane Proteases.The Effects of Extracellular Serum Concentration on APP Processing in Npc1-Deficient APP-Overexpressing N2a Cells.Alteration in Fluidity of Cell Plasma Membrane in Huntington Disease Revealed by Spectral Phasor Analysis.Plasma lipids metabolism in mild cognitive impairment and Alzheimer's disease.Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging.Phosphatidylserine containing omega-3 Fatty acids may improve memory abilities in nondemented elderly individuals with memory complaints: results from an open-label extension study.An in vitro study of the role of docosahexaenoic acid in human tau protein aggregation.The phospholipid composition of the human entorhinal cortex remains relatively stable over 80 years of adult aging.Comparative atomic-scale hydration of the ceramide and phosphocholine headgroup in solution and bilayer environmentsBiochemical and immunological aspects of protein aggregation in neurodegenerative diseases
P2860
Q28391606-5E059D70-BE20-42DB-9D4E-8E9FB2BA15CDQ28547451-19317152-90DB-41B4-8219-4B883461895CQ33592538-5E74F353-9954-4DA7-BCC3-8F3C2815EBB9Q35885375-49DA7CA8-CD2A-4DB0-A4F2-AEEB7B5D25BBQ37163086-AF076253-2A5F-4822-9299-7AEAA70C0B25Q38125769-4BF5B88C-3E55-44F4-8AB6-2BCCDDD1197EQ38147080-FB4BBFE6-0813-40AA-A3DC-2D16AE4D4991Q38591116-1E347234-5A8B-4658-A6AD-3E1FD7F4193EQ38592243-C31AEA37-2B09-460A-8514-704E17D5E757Q38681920-C8C9F64F-A4E5-4876-ABCC-DD5A670B892AQ38808541-95EFA838-69A8-4786-B43D-840573A95CD3Q39181900-A9502A0B-03EA-43B2-8A42-9EF276F85C7CQ39320214-6A662888-2114-471C-A288-9369F4FECA4AQ39474261-90DF471D-04CE-4FD6-9961-AF3684A68001Q41140593-838150C1-5067-4445-B662-DC7538848C39Q41598901-A01C6038-D38A-428C-8064-D1C55CE104F8Q42365669-CA42604E-5FFE-4C4A-A287-5E8AF4D98922Q42655692-58897948-EAAE-40CC-94EB-74C07800692EQ42736295-42A3E591-C7DA-4922-9077-BA81B8565352Q43246920-D1C84F24-B5FE-4891-A4A2-70C2A75C7EBDQ46252648-6D9C55DA-5E0B-47DE-96C6-4E5B3861C6C6Q46358154-047F2F14-C829-4590-8F77-F9218A9FA469Q47232868-288426D2-61A8-4A9A-95E7-9A2670BC6DC2Q47625709-D67E26A9-19D3-47C2-8DCF-9CE37FE5363AQ49475422-EA2AE39D-1919-45BB-8654-EC71CAA8900FQ50041775-C39E4D13-9544-420B-B7D8-2F9060CB80CEQ50417000-EFF062E6-98F8-4483-A55F-DDBAF19C6EC7Q50684270-3AC48F11-9AD8-466D-85CB-C31778E73787Q51381442-91A58DBA-18C5-4D96-B9B6-D7DC1F1D526AQ54878401-A19B1AA4-7A7A-459D-9B47-4E4D36365762Q56875875-476396EE-C477-4581-8977-8C9575B4B698Q57405353-C9287C85-917B-4003-9473-250705CF98C2
P2860
Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers.
@ast
Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers.
@en
type
label
Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers.
@ast
Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers.
@en
prefLabel
Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers.
@ast
Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers.
@en
P2860
P921
P356
P1476
Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers.
@en
P2093
Marko Kosicek
Silva Hecimovic
P2860
P304
P356
10.3390/IJMS14011310
P407
P5008
P577
2013-01-10T00:00:00Z